The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Intra-patient genomic heterogeneity of single circulating tumor cells (CTCs) associated to phenotypic CTC heterogeneity in metastatic castrate resistant prostate cancer (mCRPC).
 
Mark Landers
No Relationships to Disclose
 
Stephanie Greene
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Nicole A. Schreiber
No Relationships to Disclose
 
Angel Rodriguez
Employment - Epic Sciences
 
Richard Martin Bambury
Leadership - Portable Medical Technology
Stock and Other Ownership Interests - Portable Medical Technology
 
Daniel Costin Danila
Consulting or Advisory Role - Astellas Pharma
Research Funding - Veridex
 
Dana E. Rathkopf
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene (Inst); Janssen Oncology (Inst); Medivation (Inst); Takeda (Inst)
 
Martin Fleisher
No Relationships to Disclose
 
Jessica Louw
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Adam Jendrisak
Employment - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
 
Dena Marrinucci
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Patents, Royalties, Other Intellectual Property - Epic Sciences
 
Ryan Vance Dittamore
Employment - Epic Sciences
Leadership - Epic Sciences
Stock and Other Ownership Interests - Epic Sciences
Patents, Royalties, Other Intellectual Property - Patents Pending
 
Howard I. Scher
Honoraria - Chugai Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endo Pharmaceuticals; Endocyte; Exelixis; Ferring; Foundation Medicine; Genentech; Janssen; Medivation; OncologySTAT; Palmetto GBA; Pfizer; Sanofi; Takeda; Ventana Medical Systems; WIRB-Copernicus Group
Speakers' Bureau - WebMD
Research Funding - BIND Biosciences (Inst); Exelixis (Inst); Janssen (Inst); Janssen Diagnostics (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Endocyte; Exelixis; Ferring; Genentech; Janssen; Pfizer; Sanofi; Takeda; WIRB-Copernicus Group